Add BrightSurf on Google Email

Vanderbilt University Medical Center


AI aids efforts to cut nuisance alerts for health care teams: Study

A new study from Vanderbilt University Medical Center demonstrates the potential of AI to help target computerized alerts intended for healthcare teams. The approach uses machine learning to analyze user interactions with alerts, predicting when specific alerts will be dismissed by users. The model's suggestions were found to align wit...

SourceVanderbilt University Medical Center·JournalJournal of the American Medical Informatics Association·DateFeb 22, 2024

Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes

A large, diverse genetic study identified novel genetic locations associated with primary open-angle glaucoma (POAG), a leading cause of irreversible blindness globally. The study implicated vascular and cancer-related genes in POAG risk, with 20% of associated genes related to primary cilia.

SourceVanderbilt University Medical Center·JournalCell Reports Medicine·TypeData/statistical analysis·DateFeb 20, 2024

Novel C. diff structures are required for infection, offer new therapeutic targets

Researchers at Vanderbilt University Medical Center discovered iron storage 'spheres' inside C. diff bacteria, which are crucial for infection and offer new targets for antibacterial drugs. The study, published in Nature, also reveals that bacteria may compartmentalize biochemical processes in a way similar to eukaryotic cells.

SourceVanderbilt University Medical Center·JournalNature·TypeExperimental study·DateNov 15, 2023

Cut salt, cut blood pressure

A study from Vanderbilt University Medical Center found that reducing sodium intake by just one teaspoon a day can lower systolic blood pressure by about 6 millimeters of mercury. Most people, regardless of whether they are already on blood pressure medications or not, can see a reduction in their blood pressure if they lower the sodiu...

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A phase 3 clinical trial demonstrated tirzepatide's effectiveness in achieving an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or overweight comorbidities. Participants who received tirzepatide achieved a total mean weight loss of 26.6%, compared to 3.8% for those on placebo.

SourceVanderbilt University Medical Center·JournalNature Medicine·DateOct 17, 2023

Diabetes drugs associated with fewer adverse cardiac events in older veterans

A retrospective cohort study of U.S. veterans found that adding a GLP1 receptor agonist to diabetes treatment reduced the risk of major adverse cardiovascular events and heart failure hospitalization by about 20% compared to DPP4 inhibitors. The study's findings will aid clinicians in choosing a diabetes drug regimen for older patients.

SourceVanderbilt University Medical Center·JournalAnnals of Internal Medicine·TypeObservational study·DateMay 8, 2023

Low-professionalism residents later draw higher patient complaints: Study

A recent study by Vanderbilt University Medical Center found that early-career physicians who scored lower on professionalism and interpersonal communication skills during their residency are more likely to receive unsolicited patient complaints in their first year of employment. The study tracked 9,340 residents and found a strong ass...

SourceVanderbilt University Medical Center·JournalJAMA Network Open·DateApr 13, 2023